Kay Clark

Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections

Daniel K. Benjamin, Timothy Driscoll, Nita L. Seibel et al. · Antimicrobial Agents and Chemotherapy · 2006 · 211 citations · Full text

Antifungal Agent, Antifungal Agents, Pharmacology +12

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

Carlos M. Barrera, Analía Mykietiuk, Hristo Metev et al. · The Lancet Infectious Diseases · 2016 · 100 citations

Antimicrobial Stewardship, Antibiotics, Community-acquired Bacterial Pneumonia +8

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

David Oldach, Kay Clark, Jennifer Schranz et al. · Antimicrobial Agents and Chemotherapy · 2013 · 78 citations · Full text

Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects

James Still, Jennifer Schranz, Thorsten P. Degenhardt et al. · Antimicrobial Agents and Chemotherapy · 2011 · 63 citations · Full text

Nutrition, Pharmaceutical Science, Oral Bioavailability +17

Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects

Keith A. Rodvold, Mark H. Gotfried, James Still et al. · Antimicrobial Agents and Chemotherapy · 2012 · 51 citations · Full text

Immunology, Oral Solithromycin, Pathology +20